Direkt zum Inhalt
Merck
  • Regulation of epithelial-mesenchymal transition and metastasis by TGF-β, P-bodies, and autophagy.

Regulation of epithelial-mesenchymal transition and metastasis by TGF-β, P-bodies, and autophagy.

Oncotarget (2017-12-22)
Shana D Hardy, Aparna Shinde, Wen-Horng Wang, Michael K Wendt, Robert L Geahlen
ZUSAMMENFASSUNG

Processing bodies (P-bodies) are ribonucleoprotein complexes involved in post-transcriptional mRNA metabolism that accumulate in cells exposed to various stress stimuli. The treatment of mammary epithelial cells with transforming growth factor-beta (TGF-β), triggers epithelial-mesenchymal transition (EMT), and induces the formation of P-bodies. Ectopic expression of the transcription factor TWIST, which stimulates EMT downstream of the TGF-β receptor, also promotes P-body formation. Removal of TGF-β from treated cells results in the clearance of P-bodies by a process that is blocked by inhibitors of autophagy. Activators of autophagy enhance P-body clearance and block EMT. Blockage of P-body formation by disruption of the gene for DDX6, a protein essential for P-body assembly, blocks EMT and prevents tumor cell metastasis

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Anti-p62/SQSTM1 in Kaninchen hergestellte Antikörper, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
DBeQ, ≥98% (HPLC)
Sigma-Aldrich
MISSION® esiRNA, targeting human DDX6